High-dose Vitamin B12 May Improve ALS Prognosis if Started Early, Study Suggests Written by | Treatment with ultra-high-dose methylcobalamin, the physiologically active form of vitamin B12, may improve the prognosis of patients with amyotrophic lateral sclerosis (ALS) who receive it a year or less after symptom onset, a long-term study of Japanese reports
Experimental studies injury type A In an experimental in-vivo rattail model, intervertebral discs were loaded for 1.5 hours with approximately 300% body weight (12.6 N) at 1 Hz
Notably, researchers have documented that the peptide appears to upregulate NO production when it is deficient and downregulate it when excessive, suggesting a modulatory rather than simply stimulatory relationship
Clinical trial data on Tirzepatide, the most structurally similar approved compound, shows that participants maintaining adequate dietary fat had substantially lower gallbladder event rates than those who eliminated fats in an attempt to accelerate weight loss
How Much Does MIC B12 Cost
